Akers Biosciences Responds to Erroneous Earnings Call Press Release
February 17 2021 - 1:45PM
Business Wire
Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER) confirmed
that a press release issued earlier today with respect to an
earnings call by Aker ASA was issued by a company wholly unrelated
to the Company. The press release was errantly issued by the
newswire services under the Company’s name. The Company has not
scheduled any earnings calls. The Company is investigating how this
error occurred and reserves all rights to pursue all appropriate
remedies upon learning more about the cause of this error.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210217005868/en/
Investor Relations: Hayden IR Brett Mass, Managing Partner
Phone: (646) 536-7331 Email: brett@haydenir.com
www.haydenir.com
Akers Biosciences (NASDAQ:AKER)
Historical Stock Chart
From Jan 2025 to Feb 2025
Akers Biosciences (NASDAQ:AKER)
Historical Stock Chart
From Feb 2024 to Feb 2025